Antonio Febbraro - ASST Fatebenefratelli Sacco

基本信息

浏览量：65

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 113 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Phase II Randomized Trial Comparing Metronomic Anthracycline-Containing Chemotherapy Versus Standard Schedule in Untreated HER2 Negative Advanced Breast Cancer: Activity and Quality of Life Results of the GOIM 21003 Trial

Laura Orlando,Evaristo Maiello,Michele Orditura,Anna Diana, Giuliano Antoniol,Maria Grazia Morritti,Michele Aieta,Mariangela Ciccarese,Salvatore Pisconti,Roberto Bordonaro,Antonio Russo,Antonio Febbraro,Paola Schiavone,Annamaria Quaranta,Chiara Caliolo, Dario Loparco,Margherita Cinefra,Giuseppe Colucci,Saverio Cinieri

BREAST (2024)

引用0浏览0WOS引用

Comprehensive Genomic Profiling by Liquid Biopsy Captures Tumor Heterogeneity and Identifies Cancer Vulnerabilities in Patients with RAS/BRAF Wild Type Metastatic Colorectal Cancer in the CAPRI 2-GOIM Trial

D. Ciardiello, L.B. Bielo, S. Napolitano, E. Martinelli, T. Troiani, A. Nicastro, T.P. Latiano, P. Parente, E. Maiello, A. Avallone, N. Normanno, S. Pisconti,C. Nisi, R. Bordonaro, A.E. Russo, E. Tamburrini, I. Toma, C. Lotesoriere, S. Vallarelli, M.G. Zampino, N. Fazio, G. Curigliano, F. De Vita, F. Ciardiello, G. Martini, Davide Ciardiello,Luca Boscolo Bielo, Stefania Napolitano, Erika Martinelli, Teresa Troiani,Antonella Nicastro,Tiziana Pia Latiano,Paola Parente,Evaristo Maiello,Antonio Avallone, Nicola Normanno, Salvatore Pisconti, Claudia Nisi, Roberto Bordonaro, Alessia Erika Russo,Emiliano Tamburrini,Ilaria Toma,Claudio Lotesoriere,Simona Vallarelli,Maria Giulia Zampino, Nicola Fazio,Giuseppe Curigliano, Fortunato Ciardiello, Giulia Martini, Sara Lonardi, Chiara Cremolini,Carlo Garufi, Pierosandro Tagliaferri, Giampaolo Tortora, Filippo Pietrantonio,Antonio Febbraro, Gerardo Rosati,Silvana Leo, Oronzo Brunetti, Rosanna Berardi, Saverio Cinieri, Mario Scartozzi, Alberto Zaniboni,Giancarlo Paoletti

Annals of Oncology (2024)

引用0浏览0引用

Intermittent or Continuous Panitumumab Plus Fluorouracil, Leucovorin, and Irinotecan for First-Line Treatment of RAS and BRAF Wild-Type Metastatic Colorectal Cancer: the IMPROVE Trial

Journal of clinical oncology official journal of the American Society of Clinical Oncologypp.JCO2400979-JCO2400979, (2024)

引用0浏览0WOS引用

6MO Evaluation of Plasma Assessed Comprehensive Genomic Profiling Before First-Line Treatment with FOLFIRI Plus Cetuximab in RAS/BRAFV600E Wild Type Metastatic Colorectal Cancer Patients in the CAPRI 2-GOIM Trial

G. Martini, E. Martinelli, T. Troiani, S. Napolitano, A. Nicastro, E. Maiello, S. Pisconti, E. Tamburini, A. Avallone, R. Bordonaro,C. Lotesoriere, S. Lonardi,D. Iacono, B. Borrelli, P.S. Tagliaferri, G. Tortora, C. Damonte,A. Febbraro, F. Ciardiello, D. Ciardiello

Annals of Oncology (2024)

引用0浏览0引用